News

rss

Dental Board

News and Announcements

Saturday, April 8, 2017 Meeting: Opioid prescribing by dentists

The Ohio State Dental Board Law and Rules Review Committee Chair, Marybeth Shaffer, D.M.D., has called a special meeting of the Law and Rules Review Committee for April 8, beginning at 10:30 a.m. for the purpose of discussing proposed opioid prescribing requirements for dentists.

 The Committee meeting is open to the public and will be held in Conference Room A of the Grandview Heights Public Library, 1685 West First Avenue, Columbus Ohio 43212.

Extends Licensure Deadline for Previously Exempted Prescriber Locations that Store Controlled Substances

On April 4, 2017, the State of Ohio Board of Pharmacy adopted the following resolution: Resolution: Extension for Licensure of Entities Possessing Controlled Substances (Adopted 4.3.2017)

The Board hereby grants an extension to all previously exempted prescribers that possess controlled substances in their offices from the requirement to obtain a terminal distributor of dangerous drugs license in accordance with section 4729.541 of the Revised Code. This extension is hereby valid until June 1, 2017.

 This resolution extends the TDDD licensing requirement for these exempted prescribers to June 1, 2017. Wholesalers will still be permitted to sell to these locations during this extension period.   

After June 1, 2017, a wholesaler shipping controlled substances to any prescriber office in Ohio must verify the prescriber is appropriately licensed as a Category III Terminal Distributor of Dangerous Drugs by the State of Ohio Board of Pharmacy.

 For more information on this requirement, please visit: www.pharmacy.ohio.gov/TDDDcs

“Acute Prescribing Rules Announced”

On Thursday, March 30, 2017, Ms. Constance Clark, R.D.H., the Board’s president, joined Governor John R. Kasich and other leadership to announce new limits on opioid prescribing for acute pain. These proposed rules will be discussed by the Board during a special meeting of the Laws and Rules Committee on Saturday, April 8, 2017 at 10:30AM at the Grandview Public Library.  The Rules will then be presented to the full Board and will go through the standard rule review and adoption process.

Acute Prescribing Rules FAQs

For more information on the proposed rules, click here.

TDDD- Update as of March 10, 2017

If you hold a General Anesthesia or IV Conscious Sedation Permit with the Ohio State Dental Board, on January 4, 2017, Governor Kasich signed House Bill 319, which requires all locations which possess controlled substances to obtain a Terminal Distributor of Dangerous Drugs (TDDD) license with the Ohio Board of Pharmacy.  Please review the Guidance Document which was published by the Ohio Board of Pharmacy and the Terminal Distributor of Dangerous Drugs License Application, which are attached to this email.

If you have additional questions about this license, you should contact the Ohio Board of Pharmacy at 614-466-4143 or via email at contact@pharmacy.ohio.gov.  For any unresolved questions, please contact the Dental Board at 614-466-2580 or via email dental.board@den.ohio.gov

Terminal Distributor of Dangerous Drugs (TDDD)

If you hold a General Anesthesia or IV Conscious Sedation Permit with the Ohio State Dental Board, on January 4, 2017, Governor Kasich signed House Bill 319, which requires all locations which possess controlled substances to obtain a Terminal Distributor of Dangerous Drugs (TDDD) license with the Ohio Board of Pharmacy.  Please review the Guidance Document which was published by the Ohio Board of Pharmacy and the Terminal Distributor of Dangerous Drugs License Application, which are attached to this email.

If you have additional questions about this license, you should contact the Ohio Board of Pharmacy at 614-466-4143 or via email at contact@pharmacy.ohio.gov.  For any unresolved questions, please contact the Dental Board at 614-466-2580 or via email dental.board@den.ohio.gov

 


TDDD Requirements for Controlled Substances

All locations that possess controlled substances are required to obtain licensure as a category III terminal distributor of dangerous drugs from the State of Ohio Board of Pharmacy. This requirement applies to all locations and includes previously exempted prescriber practices (dentist, solo-practitioners, etc.) if they possess controlled substances.  Please be advised that this requirement takes effect on April 6, 2017. More information on this provision can be found by visiting: www.pharmacy.ohio.gov/TDDDcs.



Banned Devices; Powdered Surgeon's Gloves, Powdered Patient Examination Gloves, and Absorbable Powder for Lubricating a Surgeon's Glove

Please see the link for The Rule, in its entirety, is here:  https://www.federalregister.gov/documents/2016/12/19/2016-30382/banned-devices-powdered-surgeons-gloves-powdered-patient-examination-gloves-and-absorbable-powder

Updated Permissible Practices

Dental Hygienist: 
http://www.dental.ohio.gov/Licensure/DentalHygienist.aspx 

Dental Assistant: 
http://www.dental.ohio.gov/Licensure/DentalAssistantRadiographer.aspx

EFDA's: http://www.dental.ohio.gov/Licensure/ExpandedFunctionDentalAuxiliary.aspx

 

Helpdesk for Radiographers and EFDAs

NEW:  There is a helpdesk set up for Radiographers and EFDAs having trouble registering/renewing on the new eLicense portal www.elicense.ohio.gov

Toll free: 855-405-5514
Local: 614-728-4077

Radiographers will be required to upload proof of completing a continuing education course from this past biennium.

As a reminder the OSDB does not approve individual continuing education courses.  Coursework must be taken through a Board-approved or Board-accepted sponsor that meets the specific requirements for your credential.  Permanent sponsors can be located on the OSDB website under Continuing Education tab, Sponsors of Continuing Education.  Additional Radiographer CE requirements are found in the Dental Practice Act, rule 4715-12-05.

Friendly Reminder to Adhere to Prescribing Laws and Rules

Friendly Reminder to Adhere to Prescribing Laws and Rules

This is a friendly reminder to ensure that you are aware and adhering to Ohio’s Automated Rx Reporting System (OARRS) statute, updated rule 4715-6-01, Standards and Procedures for Review of OARRS, and opioid prescribing guidelines developed by the Governor’s Cabinet Opiate Action Team.  For your convenience, related documents are attached to this letter. 

As you already know, prescription opioids are a significant contributor to unintentional drug overdose deaths in Ohio.  Dentists have an opportunity to lead the way in preventing prescription drug misuse, abuse and overdose incidents.  In this regard, we strongly urge you to please follow all applicable laws and rules along with leveraging a potpourri of tools at your disposal.  Some of these tools consist of:

• Acute prescribing video at http://dental.ohio.gov/ContinuingEducation/GCOATOpioidVideoExercise.aspx
Prevention of prescription opioid abuse: The role of the dentist - University of Kentucky 
http://www.uky.edu/~pjsamm1/Dentists%20Role%20in%20Preventing%20Prescription%20Opioid%20Abuse.pdf 
Prescriber guidelines at http://mha.ohio.gov/Default.aspx?tabid=828
OARRS website at https://www.ohiopmp.gov/Portal/Default.aspx 
Printable pocket cards for prescribers at www.pharmacy.ohio.gov/rxcheck
http://www.pharmacy.ohio.gov/Documents/LawsRules/RuleChanges/OARRSRules/When%20to%20Check%20OARRS%20-%20Pocket%20Card%20-%20Prescribers%20and%20Pharmacists.pdf
Online video tutorial for prescribers at www.pharmacy.ohio.gov/oarrsvid
http://www.pharmacy.ohio.gov/Licensing/Quiz/2016OarrsCE/Quiz.aspx
Online video tutorials on how to register, run and read a patient report in the OARRS system at www.oarrs.pharmacy.ohio.gov      
https://www.ohiopmp.gov/Portal/Default.aspx

Please understand that it is the intention of the Dental Board to fully enforce all applicable OARRS laws and rules through a new monthly OARRS monitoring protocol being established.  Data from OARRS will be reviewed for non-compliance indicators that may lead to an inquiry for a marginal concern and an investigation for a substantial concern.  

Thanking you in advance for your anticipated support in Ohio’s fight against prescription opioid abuse.

Sincerely,


                                                     
Marybeth D. Shaffer, DMD                                                                     Harry N. Kamdar, MBA

Board President                                                                                       Executive Director